[3P-1426] Dual-targeting anti-angiogenic cyclic peptides as potential drug leads for cancer therapy

〇LAI YUE CHAN¹、David J. Craik¹、Norelle L. Daly² (1.The University of Queensland, Institute for Molecular Bioscience, Australia.、2.Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Australia.)

disulfide-rich cyclic peptides、angiogenesis inhibitors、cancer、stable、non-toxic